Icon

FLUXID (nda021712)- (20MG,40MG)

FAMOTIDINE UCB INC
20MG,40MG
No Yes
2018-Apr-09 Expired
None None
None No
FLUXID™ is indicated in: 1. Short term treatment of active duodenal ulcer 2. Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of an active ulcer 3. Short term treatment of active benign gastric ulcer 4. Short term treatment of gastroesophageal reflux disease (GERD) 5. Treatment of pathological hypersecretory conditions.
0 0 0
Total Other Developers None
Drugs with Suitability No
20MG ** ** - - -
40MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.